CRISPR-Q
Qiagen GmbH
Trademark Registered: 2022-09-27
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79326535 |
| Registration Number | 6854769 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2021-06-18 | Application Filed |
| 2021-11-25 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-11-25 | Status: Live/Pending |
| 2021-11-29 | Transaction Date |
| 2022-09-27 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Qiagen GmbH |
| Entity Statement | GmbH |
| Address | Qiagen Str. 1 40724 Hilden EU |
| Legal Entity Type | |
| Legal Entity State | EU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Chemical, biochemical and biotechnological diagnostic preparations for scientific use, non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes |
| GS0051 | Diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of acids; diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-11-25 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-11-29 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-12-03 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-03-10 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-03-15 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-03-16 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2022-04-26 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-04-26 | 8 RFCS P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-05-12 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-05-12 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-05-12 | 11 TEME I:Incoming Correspondence |
| REFUSAL PROCESSED BY IB | 2022-05-16 | 12 RFNT P: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-06-09 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-06-22 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2022-06-29 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-06-29 | 16 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2022-07-12 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-07-12 | 18 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2022-07-19 | 19 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2022-09-27 | 20 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-09-27 | 21 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-12-27 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2023-01-25 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2023-01-25 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-02-14 | 25 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 